zur Stadt, U <br/><br/>
[Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].  [electronic resource] 

 -  Klinische Padiatrie   
 - 169-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial; English Abstract; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0300-8630 
<br/><br/><label>Standard No.: </label>10.1055/s-2000-9672  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asparaginase--administration & dosage<br/>Biopsy, Needle<br/>Bone Marrow--drug effects<br/>Child<br/>Child, Preschool<br/>Daunorubicin--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Neoplasm, Residual<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--diagnosis<br/>Prednisolone--administration & dosage<br/>Prognosis<br/>Recurrence<br/>Treatment Outcome<br/>Vincristine--administration & dosage